PVP Labs
Singapore-based biotechnology company focused on discovery and development of peptide-based therapeutics. The organization emphasizes peptide drug design, formulation for multiple delivery routes (topical, intranasal/inhalation, injectable), preclinical evaluation, and commercialization-support activities including intellectual property management.
Industries
Nr. of Employees
small (1-50)
Patents
Antiviral immunotropic agent for the treatment of acute respiratory viral infections
US-11365216-B2
View DetailsDrug for the effective control of acute and or chronic pain and a method for its administration
US-10357533-B2
View Details
Antiviral immunotropic agent for the treatment of acute respiratory viral infections
US-11365216-B2
View DetailsDrug for the effective control of acute and or chronic pain and a method for its administration
US-10357533-B2
View DetailsProducts
Taphalgin
Non-addictive tetrapeptide analgesic developed as a dual-mechanism agent combining μ1-selective opioid receptor agonism and calcium channel modulation for rapid acute pain control.
Arvidal
Host-directed antiviral and immunotropic peptide formulated as a mucosal spray intended to provide prophylactic and therapeutic protection against acute respiratory viral infections by enhancing local immunity and promoting epithelial repair.
Dalardenol
Topical reparative peptide candidate intended for faster, scar-sparing healing of burns and complex wounds with analgesic and anti-inflammatory local effects; available in spray and gel formats.
Taphalgin
Non-addictive tetrapeptide analgesic developed as a dual-mechanism agent combining μ1-selective opioid receptor agonism and calcium channel modulation for rapid acute pain control.
Arvidal
Host-directed antiviral and immunotropic peptide formulated as a mucosal spray intended to provide prophylactic and therapeutic protection against acute respiratory viral infections by enhancing local immunity and promoting epithelial repair.
Dalardenol
Topical reparative peptide candidate intended for faster, scar-sparing healing of burns and complex wounds with analgesic and anti-inflammatory local effects; available in spray and gel formats.
Services
Discovery and optimization of peptide sequences for therapeutic applications across pain, antiviral and wound-healing indications.
Development of topical sprays/gels, intranasal and inhalation solutions, and injectable formulations for peptide candidates.
In vitro and in vivo pharmacology and efficacy studies to evaluate therapeutic activity and inform translational decisions.
Patent filing and management for peptide compositions and delivery methods supporting long-term protection.
Discovery and optimization of peptide sequences for therapeutic applications across pain, antiviral and wound-healing indications.
Development of topical sprays/gels, intranasal and inhalation solutions, and injectable formulations for peptide candidates.
In vitro and in vivo pharmacology and efficacy studies to evaluate therapeutic activity and inform translational decisions.
Patent filing and management for peptide compositions and delivery methods supporting long-term protection.
Expertise Areas
- Peptide drug discovery
- Peptide formulation development (topical, mucosal, inhalation, injectable)
- Host-directed antiviral therapeutics
- Analgesic peptide development
Key Technologies
- Peptide therapeutics
- Mucosal delivery (intranasal/oropharyngeal spray, inhalation)
- Topical spray and gel formulations
- Injectable peptide formulations